01 3Orion Corporation
02 4Alfred E Tiefenbacher GmbH
03 3Breckenridge Pharmaceutical
04 4Douglas CDMO
05 4Pharmathen SA
06 42care4
07 5A Pharma Gmbh
08 10Actavis Inc
09 17Almirall
10 3Alvogen
11 3Amneal Pharmaceuticals
12 3Apotex Fermentation Inc.
13 3Aristo Pharma GmbH
14 3Ascent Innovative Medicines
15 12Aurobindo Pharma Limited
16 3Aurovitas Spain, Sau
17 5Biofarma Pharmaceutical Industry and Commerce Inc
18 3Cinfa
19 3DOC Generici
20 5Esteve Quimica
21 5Hexal AG
22 2Jeil Pharmaceutical Co., Ltd
23 3Kern Pharma S.L.
24 3Knight Therapeutics
25 16Krka
26 4LABORATORIOS NORMON SA
27 4Macleods Pharmaceuticals Limited
28 2Myungmoon Pharm. Co., LTD.
29 10Neuraxpharm
30 81Novartis Pharmaceuticals Corporation
31 4Novartis South Africa (Pty) Ltd
32 1ORIFARM GROUP AS
33 4Orchid Pharma
34 3Ratiopharm Espana Sa
35 14STADA Arzneimittel
36 2Samyang Biopharmaceuticals
37 29Sandoz B2B
38 2Tecnimede
39 13Teva Pharmaceutical Industries
40 8Torrent Pharmaceuticals Limited
41 13Viatris
42 4Vir Sa Chemical And Pharmaceutical Industry
43 5World Medicine
44 3Yichang Humanwell Pharmaceutical
45 7Zentiva
46 3Zydus Pharmaceuticals
01 8CAP
02 16CAPSULE
03 53Capsule
04 3ER Film
05 21FILM, EXTENDED RELEASE;TRANSDERMAL
06 3H Transdermal Patch
07 2H Transdermal Patches
08 40Hard Capsule
09 8Hard Capsule Oral
10 12Hard Capsules
11 1ORAL SOLUTION
12 10Oral Solution
13 8Orodispersible Tablet
14 11PATCH
15 2Patch
16 1Patches
17 5Rivastigmine 1,5Mg 56 Combined Oral Use
18 5Rivastigmine 3Mg 56 Combined Oral Use
19 5Rivastigmine 4,5Mg 56 Combined Oral Use
20 3Rivastigmine 4,6Mg/Die 30 Plasters Transdermal Use
21 5Rivastigmine 6Mg 56 Combined Oral Use
22 3Rivastigmine 9,5Mg/Die 30 Plasters Transdermal Use
23 1Solution
24 1Syrup
25 102Transdermal Patch
26 2Transdermal Patches
27 14Blank
01 77Authorized
02 21Cancelled
03 3DISCN
04 4EU Approved
05 10Generic
06 4Generic Approved DCP
07 2Generic B.E study
08 4Generic EU CTD
09 11Marketed
10 7Not Marketed
11 4Originator
12 71Prescription
13 18RX
14 4Registered in EU
15 3Suspended
16 102Blank
01 3Alzerta
02 2Alzerta Dos Por Semana
03 22Astigmina
04 3DEMELORA
05 2DEMENCURE
06 13EXELON
07 1EXELON PATCH 10
08 1EXELON PATCH 15
09 1EXELON PATCH 5
10 56Exelon
11 1Exelon 1.5 mg
12 1Exelon 6 mg
13 2Exelon Patch 10
14 2Exelon Patch 15
15 2Exelon Patch 5
16 1Kyriz 1,5 MG
17 1Kyriz 3 MG
18 1Kyriz 4,5 MG
19 1Kyriz 6 MG
20 1MYLAN-RIVASTIGMINE PATCH 10
21 1MYLAN-RIVASTIGMINE PATCH 5
22 4NIMVASTID
23 8Nimvastid
24 4Nvastid
25 33Prometax
26 4RIVASTIGMINA AUROBINDO
27 3RIVASTIGMINA DOC
28 4RIVASTIGMINA MYLAN PHARMA
29 5RIVASTIGMINA SANDOZ
30 2RIVASTIGMINA SANDOZ GMBH
31 1RIVASTIGMINA SANDOZ GmbH
32 18RIVASTIGMINE
33 3RIVASTIGMINE ZENTIVA
34 5RIVASTORON
35 2Rigmin
36 5Ristart
37 3Rivanex
38 4Rivanex Flas
39 2Rivaron
40 3Rivastigmin Tevagen
41 3Rivastigmina Aristo
42 3Rivastigmina Aurovitas Spain
43 3Rivastigmina Cinfa
44 3Rivastigmina Kern Pharma
45 3Rivastigmina Ratio
46 3Rivastigmina Sandoz
47 3Rivastigmina Stadafarma
48 2Rivastigmina Tecnigen
49 3Rivastigmina Teva
50 2Rivastigmina Viatris
51 4Rivastigmina Vir
52 5Rivastigmine 1 A Pharma
53 4Rivastigmine Actavis
54 3Rivastigmine Apotex
55 5Rivastigmine Hexal
56 4Rivastigmine Normon
57 3Rivastigmine Ratiopharm
58 5Rivastigmine Sandoz
59 8Rivastigmine Stada
60 2Rivastigmine Zentiva
61 2Rivastigmine "Actavis"
62 3Rivastigmine "Stada Arzneimittel"
63 3Rivastor
64 1SANDOZ RIVASTIGMINE PATCH 10
65 1SANDOZ RIVASTIGMINE PATCH 5
66 33Blank
01 14Australia
02 7Canada
03 21Denmark
04 43Estonia
05 4Germany
06 4Greece
07 15India
08 65Italy
09 4New Zealand
10 18Norway
11 8South Africa
12 6South Korea
13 101Spain
14 10Turkey
15 21USA
16 4United Kingdom
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 20-02-2020
Application Number : 28106209018
Regulatory Info : Prescription
Registration Country : Denmark
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 4.6MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 16-04-2013
Application Number : 28104887211
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 16-04-2013
Application Number : 28104887311
Regulatory Info : Prescription
Registration Country : Denmark
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 9.5MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 13.3MG/24HR
Packaging :
Approval Date : 2019-11-26
Application Number : 209063
Regulatory Info : RX
Registration Country : USA
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 4.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : CAPSULE
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 4.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : EXELON
Dosage Form : FILM, EXTENDED RELEASE;TRANSDERMAL
Dosage Strength : 4.6MG/24HR
Packaging :
Approval Date : 2007-07-06
Application Number : 22083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rivastigmin Tevagen
Dosage Form : Transdermal Patch
Dosage Strength : 13.3MG
Packaging :
Approval Date : 05-04-2022
Application Number : 86432
Regulatory Info : Authorized
Registration Country : Spain
